CardioPoint™ is a next-generation biomedical innovation designed to revolutionize emergency cardiac care.

 

Targeting one of the most critical gaps in field medicine: the inability of traditional AEDs to restore heartbeat during asystole (flatline) or in high-impedance trauma scenarios.

​

Where defibrillators fail, CardioPoint delivers.

 

Technology Overview

At its core, CardioPoint uses a percutaneously inserted dual-needle electrode to deliver precisely timed biphasic electrical pulses directly to the myocardium. The system is engineered for use in austere military, remote, and disaster environments, where every second counts and power must be efficient.

​

Key Capabilities

• 2ms biphasic pulse delivery at 5–20V, 10mA output

• Sub-millijoule energy pulses (<< 0.5mJ) for tissue-safe, effective myocardial capture

• H-Bridge circuit architecture for polarity control

• MCU-controlled timing firmware for adaptive delivery

• Biocompatible dual-needle design inspired by acupuncture and neurostimulation research

• Portable, rugged form factor for deployment in field packs or response kits

​

Reduces preventable deaths during cardiac arrest

in combat or civilian disaster zones

 

Enables treatment when AEDs are ineffective or unavailable

 

CardioPoint™ is designed to be deployed before EMS arrival,

integrated with NextGen 911 systems, 911 Informatics Kiosks, and battlefield telemetry.

​